Inventor
FALGOUT BARRY
US7 patents
⚠️ This page may combine multiple inventors who share the name “FALGOUT BARRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
3 patentsUS7517531B2Apr 14, 2009
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
US HEALTH17 citations91
US11753627B2Sep 12, 2023
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
US HEALTH0 citations61
US10837003B2Nov 17, 2020
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US HEALTH0 citations50
WHITEHEAD STEPHEN S
2 patentsUS8075903B2Dec 13, 2011
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
WHITEHEAD STEPHEN S14 citations90
US9783787B2Oct 10, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
WHITEHEAD STEPHEN S5 citations82
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
2 patentsUSRE46641EDec 19, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES5 citations83
USRE46631EDec 12, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES7 citations83